FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, to chemical-pharmaceutical industry, namely to a pharmaceutical composition exhibiting anti-ulcerative activity in the form of a solid dosage form. Composition consists of a nucleus containing as an active compound dinitrate 9-diethylaminoethyl-2-phenyl-imidazo[1,2-a]benzimidazole and as auxiliary inert calcium substances dibasic phosphate, polyvinylpyrrolidone K 30, stearic acid salt coated with a polymer shell based on cellulose ether and titanium dioxide, characterized in that as auxiliary inert substances, the core additionally contains lactose monohydrate, corn starch, calcium stearate as the stearic acid salt, and the polymer coating additionally contains polyethylene glycol 6000, triacetin and lactose monohydrate. Group of inventions also relates to a method of producing a pharmaceutical composition.
EFFECT: group of inventions provides optimization of composition and technological process of obtaining tablets, optimal release characteristics of active principle, as well as stable storage for 3 years.
2 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
PHARMACEUTICAL ANTIULCEROUS COMPOSITION AND METHOD OF ITS PREPARING | 2001 |
|
RU2179022C1 |
PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696869C1 |
PHARMACEUTICAL COMPOSITION PREVENTING DEVELOPMENT OF PREEXCITATION SYNDROME | 2011 |
|
RU2453313C1 |
AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
COMPOSITION AND METHOD FOR PRODUCING A SOLID DOSAGE FORM CONTAINING (Z)-3-(2-OXO-2-(4-TOLYL)ETHYLIDENE)PIPERAZIN-2-ONE | 2017 |
|
RU2657526C1 |
PELLETISED DRUG SHOWING ANTIVIRAL AND INTERFERONOGENIC ACTION, AND METHOD FOR PREPARING IT | 2010 |
|
RU2449792C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES (VERSIONS) | 2010 |
|
RU2483717C2 |
PHARMACEUTICAL COMPOSITION OF MOXIFLOXACIN AND METHOD FOR PRODUCING IT | 2014 |
|
RU2558932C1 |
PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696866C1 |
Authors
Dates
2020-11-12—Published
2019-06-04—Filed